Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical studies with doranidazole summarized

June 29, 1998

Modulators of drug/multidrug resistance from Lilly

June 29, 1998

Tricyclic antitumor compounds developed at Schering-Plough

June 29, 1998

New class of FPTase inhibitors discovered at Merck & Co.

June 29, 1998

Melphalan derivative pinpointed for further study

June 29, 1998

rAd-p53 in gene therapy of cancers with p53 mutation; overview of gene therapies in development

June 29, 1998

Potential use of BSH in boron neutron capture therapy evaluated in clinical trials

June 26, 1998

U.K. investigators identify interesting candidate for clinical evaluation

June 26, 1998

French investigators evaluate potential cell-free antitumor vaccine

June 26, 1998

German scientists synthesize novel apoptosis-inducing agents

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...